Dr. Reddy's Laboratories Limited (RDY)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$14.02
+0.43%
Mkt Cap $11.98B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Jan 20, 2026 | $927.68M | $951.64M | +2.58% | $0.16 | $0.16 | +0.00% | — | — |
| Q4 2025 Oct 24, 2025 | $944.66M | $992.07M | +5.02% | $0.19 | $0.19 | -1.40% | — | — |
| Q3 2025 Jul 23, 2025 | $1.02B | $997.48M | -2.16% | $0.21 | $0.20 | -6.72% | — | — |
| Q2 2025 May 9, 2025 | $986.90M | $994.51M | +0.77% | $0.21 | $0.22 | +4.02% | — | — |
| Q4 2024 Nov 5, 2024 | $909.16M | $954.28M | +4.96% | $0.21 | $0.04 | -80.62% | — | — |
| Q3 2024 Jul 27, 2024 | $869.76M | $920.72M | +5.86% | $0.19 | $0.20 | +4.00% | — | — |
| Q2 2024 May 8, 2024 | — | $849.32M | — | $0.86 | $0.70 | -18.60% | — | — |
| Q1 2024 Jan 31, 2024 | $833.41M | $868.58M | +4.22% | $0.18 | $0.20 | +13.25% | — | — |
| Q4 2023 Oct 27, 2023 | $816.23M | $10.01M | -98.77% | $0.17 | $0.21 | +20.27% | — | — |
| Q3 2023 Jul 26, 2023 | $777.84M | $821.16M | +5.57% | $0.15 | $0.21 | +36.36% | — | — |
| Q2 2023 May 10, 2023 | $745.17M | $9.32M | -98.75% | $0.12 | $0.14 | +21.63% | — | — |
| Q1 2023 Jan 25, 2023 | $729.14M | $832.37M | +14.16% | $0.14 | $0.18 | +32.35% | — | — |
| Q4 2022 Oct 28, 2022 | $695.50M | $9.69M | -98.61% | $0.56 | $0.16 | -71.63% | — | — |
| Q3 2022 Jul 28, 2022 | $679.18M | $660.23M | -2.79% | $0.51 | $0.18 | -64.77% | — | — |
| Q2 2022 May 23, 2022 | $1.18B | $9.53M | -99.19% | $0.55 | $0.07 | -87.27% | — | — |
| Q1 2022 Jan 28, 2022 | $732.85M | $713.73M | -2.61% | $0.64 | $0.11 | -82.73% | — | — |
| Q4 2021 Oct 29, 2021 | $8.84M | $10.47M | +18.46% | — | $0.16 | — | — | — |
| Q3 2021 Jul 27, 2021 | $8.90M | $660.80M | +7324.85% | $0.11 | $0.09 | -18.18% | — | — |
| Q2 2021 Jun 30, 2021 | — | $8.85M | — | — | $0.00 | — | — | — |
| Q1 2021 Jan 29, 2021 | — | $673.31M | — | — | $0.08 | — | — | — |